Renal Cancer study: PSMA PET
Official title 68Ga-PSMA PET in the Renal Cell Carcinoma
ClinicalTrials.gov ID: NCT04987086
What this study is testing
- What it's testing
- The study wants to see how well the PET scan finds metastatic kidney cancer compared to a standard CT scan, and whether the PET results change doctors’ treatment choices.
- Who it's for
- Adults with locally advanced or advanced kidney cancer that has spread to other parts of the body.
- What's involved
- Participants will have a 68Ga‑PSMA PET scan and an enhanced CT scan. The results will be compared to see which imaging method detects cancer spread better.
- Time commitment
- The study involves a single imaging visit; no additional routine visits are required.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- 2017 AJCC renal cell carcinoma TNM stage III, IV lesions;
- In contrast-enhanced CT staging, suspicious metastases were found;
- There were no known peripheral or central venous problems;
- 68Ga PSMA PET / CT imaging can be performed within 6 weeks after the diagnosis of renal cell carcinoma;
- Signed the informed consent form of voluntary participation in clinical trials.
You likely can't join if
- Age ≤ 18 years old;
- Can't stand lying flat in PET / CT examination;
- There are contraindications for 68Ga PSMA ligands;
- In the past two years, there was a history of other malignant tumors, or according to the doctor's research judgment, complications may occur and...
- Renal function is impaired or hemodialysis is in progress.
The study team makes the final eligibility decision.
Where it is enrolling
- Lanzhou, Gansu, China
- Yinchuan, Ningxia, China
- Xining, Qinghai, China
- Xi'an, Shaan'xi, China
- Weinan, Shaanxi, China
- Xi'an, Shaanxi, China
- Xianyang, Shaanxi, China
- Yan’an, Shaanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Lanzhou, Gansu, China; Yinchuan, Ningxia, China; Xining, Qinghai, China; Xi'an, Shaan'xi, China; Weinan, Shaanxi, China; Xi'an, Shaanxi, China and 2 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.